SEC 13F Intelligence

Mpm Bioimpact LLC / SNDX

Mpm Bioimpact LLC’s Syndax Pharmaceuticals Inc Position

Does Mpm Bioimpact LLC own Syndax Pharmaceuticals Inc (SNDX)? Yes — 1.34M shares worth $31M (+2.42% of its 13F portfolio) as of Q1 2026, up from 1.34M shares the prior filed quarter.

Position Value
$31M
Q1 2026
Shares
1.34M
% of Portfolio
+2.42%
Quarters Held
3
currently held

Position History SNDX

Reported value by quarter
Q3 ’25: $21MQ3 ’25Q4 ’25: $28MQ4 ’25Q1 ’26: $31MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.34M$31M+2.42%
Q4 20251.34M$28M+3.22%
Q3 20251.38M$21M+3.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of SNDX.